The V-shaped recovery in Asian equity markets suggests that the region has fared relatively well compared with others. That may ring true given the lower infection rates, fewer deaths and less economic damage incurred by North Asian economies such as Taiwan, Korea and China, but the experience of these countries is not comparable to those of Southeast Asia and India, which have had less success in containing the virus.
We think the best approach is to invest in companies that are worth more than the market believes. We are looking for new stocks trading at significant discounts to our estimate of fair value, with deep discounts currently available in more cyclical areas of the market, where there is less confidence in the pace of recovery.
The companies below interest us because we feel that the pandemic is unlikely to change the long-term fundamentals and there is scope for earnings to recover faster than the market expects as conditions normalise. Furthermore, a degree of balance-sheet strength should offer the business some protection should uncertainty linger.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
A finger in every pie
Larsen & Toubro (Mumbai: LT) is an Indian conglomerate with a market-leading engineering and construction (E&C) division. The company has diversified over time, with other businesses in IT services, financial services, property development and equity investment in infrastructure projects. We believe the group has a strong management team and is well positioned to gain market share as construction activity improves after several years of underinvestment in India. Our analysis suggests that Larsen’s core E&C business is being valued below the level it reached during the global financial crisis.
Cashing in on cars
Astra International (Jakarta: ASII) has interests in a wide range of market-leading vehicle-related businesses in Indonesia, including four-wheeler manufacturing for Toyota; two-wheeler manufacturing for Honda; car dealerships and vehicle financing. Astra also own a stake in Indonesia’s largest dealer of Komatsu heavy equipment, United Tractors. The shares have derated significantly given uncertain demand due to Covid-19, having been struggling with slower growth in recent years. While the fundamentals of the Indonesian economy are weak in the short term, we believe that demand for vehicles should eventually grow as GDP per capita rises. Astra should also benefit from new Toyota model launches that are expected in 2021.
Yue Yuen Industrial (Hong Kong: 551) is the world’s largest sports shoe manufacturer, serving global brands such as Nike, Adidas and Asics. Lockdowns and store closures saw a sharp decline in sales. By early next year sales should be getting back to normal. The share price, still around 50% below where it was in January, reflects little hope of recovery. The company has relocated manufacturing capacity outside China and invested in automation and a new enterprise resource planning system to enable it to manage shorter lead times from customers better, which should aid its eventual earnings recovery. The shares are on a single digit price/earnings ratio based on our estimate of normalised earnings – a significant discount to fair value.
-
8 of the best houses for sale with annexesThe best houses with annexes – from a period property in the Lake District to a 13th-century house with a two-bedroom annexe in Saltwood, Kent
-
Zelenskyy moves to appease Donald Trump – what happens now?Ukraine’s president Volodymyr Zelenskyy is conceding ground to secure the least-worst deal possible, says Emily Hohler
-
Rolls-Royce stock jumps 15% – could it climb further?Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
-
The power of private marketsInterview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseasesVertex Pharmaceuticals operates in a profitable subsector and is poised for further success
-
Global investors have overlooked these top tips in emerging marketsOpinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
-
King Coal has not been dethroned yet — should you buy?The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
-
It’s time to start buying Europe again, says Merryn Somerset WebbOpinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fadesFood-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
-
Should investors stay bullish and buy UK and US stocks?Opinion Ignore the Eeyores, says Max King. The outlook for stocks in both Britain and America remains auspicious
